Chimeric antigen receptor T cells for cancer immunotherapy
J Clin Oncol
.
2015 May 20;33(15):1703-6.
doi: 10.1200/JCO.2014.60.3449.
Epub 2015 Apr 20.
Authors
Kevin J Curran
1
,
Renier J Brentjens
2
Affiliations
1
Memorial Sloan Kettering Cancer Center, New York, NY.
2
Memorial Sloan Kettering Cancer Center, New York, NY
[email protected]
.
PMID:
25897155
DOI:
10.1200/JCO.2014.60.3449
No abstract available
Publication types
Comment
MeSH terms
Bone Neoplasms / therapy*
Female
Humans
Immunotherapy / methods*
Male
Receptor, ErbB-2 / metabolism*
Sarcoma / therapy*
T-Lymphocytes / immunology*
Substances
Receptor, ErbB-2
Grants and funding
P30 CA008748/CA/NCI NIH HHS/United States